Nimotuzumab for the treatment of high grade of malignancy tumors |
Nimotuzumab in tumors of head and neck .Phase IV |
Squamous cell carcinoma interferons (CECIN study) |
Safety with interferon in skin carcinomas (SCIENCE study) |
Biodistribution of CIGB-300 in cervical cancer (CERVIFARM-300-II Study) |
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study) |
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study) |
Subcutaneous immunotherapy with PROLINEM -Asthma- Adults-Fase I |
D-004 in patients with Bening Prostatic Hyperplasia |
NASVAC Phase II Trial in patients with Chronic Hepatitis B Virus infection |
iorEPOCIM-Stroke-Phase I |
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series |
Effectiveness and Safety of Tenofovir + Lamivudine + Efavirenz Generic Scheme for the Treatment of HIV Infection / AIDS in Patients of the CLS,Colombia, 2012-2013. |
Heptavalent Conjugate Vaccine against Pneumococcal in healthy adults (VCN7-T). |
T1h in severe psoriasis-expanded access program (PUCE) |
Multimodal anesthesia for beating heart surgery |
HeberPAG® in Mycosis Fungoides (MYFIC Study) |
Podal Reflex Laserpuncture as a treatment for Chronic Adenoiditis - Phase III |
Academic trial of sertraline in depression |
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |